首页> 美国卫生研究院文献>Journal of Virology >Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants.
【2h】

Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants.

机译:突变型p50突变体对NF-κBp50亚基的突变分析和对NF-κB活性的抑制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The NF-kappa B family of DNA-binding proteins regulates the expression of many cellular and viral genes. Each of these proteins has an N-terminal region that is homologous to the c-Rel proto-oncogene product, and this Rel homology region defines both DNA binding and protein dimerization properties of the individual proteins. Most of the NF-kappa B family members have been shown to associate with themselves or with each other to form homodimers or heterodimers, and previous studies have shown that dimerization of NF-kappa B factors is necessary to provide a functional DNA binding domain. We have used site-directed mutagenesis to identify regions in the Rel homology domain of the p50/NF-kappa B protein that are important for DNA binding and protein dimerization. Our studies have identified mutations of p50 that interfere with DNA binding only and those that interfere with protein dimerization. Mutations of p50 which disrupt only DNA binding were still able to associate with other members of the NF-kappa B protein family. We demonstrate that such heterodimeric complexes inhibit transcriptional activation mediated in trans through a cis-acting kappa B motif; therefore, we have identified trans-dominant negative mutants of p50.
机译:DNA结合蛋白的NF-κB家族调节许多细胞和病毒基因的表达。这些蛋白质中的每一个都有一个与c-Rel原癌基因产物同源的N末端区域,而这个Rel同源区域定义了各个蛋白质的DNA结合和蛋白质二聚化特性。已显示大多数NF-κB家族成员彼此或彼此缔合形成同二聚体或异二聚体,并且先前的研究表明,NF-κB因子的二聚化对于提供功能性DNA结合结构域是必需的。我们已使用定点诱变来鉴定p50 /NF-κB蛋白的Rel同源结构域中对于DNA结合和蛋白二聚化非常重要的区域。我们的研究确定了仅干扰DNA结合的p50突变和干扰蛋白质二聚化的p50突变。仅破坏DNA结合的p50突变仍然能够与NF-κB蛋白家族的其他成员结合。我们证明了这种异二聚体复合物抑制通过顺式作用κB基序反式介导的转录激活。因此,我们已经鉴定出p50的反显性负突变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号